Amazon's chief health executive is set to leave the company, with the role being taken over by the co-founder of telemedicine firm Amwell.
The announcement, made by the e-commerce giant, marks a significant leadership transition in its healthcare division.
The move comes amid growing competition in the digital health space and as Amazon continues to expand its footprint in the sector.
The new appointee brings experience from the telemedicine industry, which could influence the direction of Amazon's health initiatives.
This leadership change is being closely watched by investors and industry observers, as it may reflect a broader strategy shift or a response to evolving market dynamics.
Amazon has previously made major investments in healthcare, including the acquisition of PillPack and the launch of its own pharmacy service.